Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder
NCT ID: NCT01340092
Last Updated: 2016-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
192 participants
INTERVENTIONAL
2011-04-30
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder
NCT05099705
Supporting the Well Being of Families of Young Children With Autism Spectrum Disorders
NCT01021384
Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder
NCT02995408
Autism Adaptive Community-based Treatment to Improve Outcomes Using Navigators (ACTION) Network
NCT03575429
Mobilizing Community Systems to Engage Families in Early Autism Spectrum Disorder (ASD) Detection & Services
NCT02445105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Family Navigator
Family navigation
Family Navigator
Families in the intervention group will receive approximately six sessions with a Family Navigator. The Family Navigator will:
1. Help family identify key issues they need to address to get their child autism-specific services
2. Help family address barriers to obtaining these services and strategize approaches to overcome them.
Standard Care
standard care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Family Navigator
Families in the intervention group will receive approximately six sessions with a Family Navigator. The Family Navigator will:
1. Help family identify key issues they need to address to get their child autism-specific services
2. Help family address barriers to obtaining these services and strategize approaches to overcome them.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Child is under 8 years of age
* Parent is the mother, father and/or legal guardian of the child and identifies themselves as the primary caregiver
* Primary caregiver speaks English, Spanish, Haitian Creole, Somali, Vietnamese, Portuguese or Chinese
Exclusion Criteria
* Parent or legal guardian endorses suicidal ideation
* Parent or legal guardian actively using illicit drugs
* Parent or legal guardian expected to leave area within 6 months
15 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marilyn Augustyn
BMC Faculty
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marilyn Augustyn, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRSA R40MC19928-01-00
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
29964
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.